Literature DB >> 2475989

Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.

R M Iorio1, R L Glickman, A M Riel, J P Sheehan, M A Bratt.   

Abstract

We have previously identified five antigenic sites on the hemagglutinin-neuraminidase (HN) glycoprotein of the Australia-Victoria isolate of Newcastle disease virus (Iorio and Bratt, J. Virol. 48, 440-450; Iorio et al., J. Gen. Virol. 67, 1393-1403). Two additional sites (designated 12 and 23) are now described, bringing to a total of seven the number of antigenic sites defined by our panel of neutralizing anti-HN antibodies. Competition antibody binding and additive neutralization assays reveal that each of these newly-identified sites overlaps two previously-defined ones. The seven HN antigenic sites thus form a continuum in the three-dimensional conformation of the molecule. Studies on the inhibition of hemagglutination (HA), neuraminidase (NA) and the attachment of virus to chick cell monolayers have been used to construct a functional profile of each antigenic site. Monoclonal antibodies (mAbs) to three overlapping sites (12, 2 and 23) inhibit HA and NA and prevent viral attachment to chick cell monolayers. These findings are consistent with the domains recognized by these mAbs being close to the NA and receptor-binding sites. MAbs to two other overlapping sites, 14 and 1 (which in turn, overlap site 12), inhibit HA quite effectively, and attachment to a lesser extent. Sites 14 and 1 probably identify a second domain involved in receptor recognition. MAbs to the two remaining sites (3 and 4), though neutralizing, are negative in all three assays, thus recognizing domains not involved in HA or NA or attachment to chick cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475989     DOI: 10.1016/0168-1702(89)90019-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  40 in total

1.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.

Authors:  Vanessa R Melanson; Ronald M Iorio
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

6.  Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.

Authors:  Christine A Baumann; Wolfgang J Neubert
Journal:  Arch Virol       Date:  2009-12-19       Impact factor: 2.574

7.  Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains.

Authors:  Judith G Alamares; Jianrong Li; Ronald M Iorio
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Newcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV.

Authors:  Olivier F Maminiaina; Patricia Gil; François-Xavier Briand; Emmanuel Albina; Djénéba Keita; Harentsoaniaina Rasamoelina Andriamanivo; Véronique Chevalier; Renaud Lancelot; Dominique Martinez; R Rakotondravao; Jean-Joseph Rajaonarison; M Koko; Abel A Andriantsimahavandy; Véronique Jestin; Renata Servan de Almeida
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

9.  Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion.

Authors:  Jianrong Li; Edward Quinlan; Anne Mirza; Ronald M Iorio
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus.

Authors:  Aruna Panda; Subbiah Elankumaran; Sateesh Krishnamurthy; Zhuhui Huang; Siba K Samal
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.